C12Y 201/03003
Ornithine carbamoyltransferase
Official title: Ornithine carbamoyltransferase (2.1.3.3)
C12Y201/03003 (Ornithine carbamoyltransferase) appears on 69 US grants and 105 published applications in this corpus.
Search patents in C12Y- Granted patents
- 69
- Published applications
- 105
- Assignees
- 36
- Inventors
- 171
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 2 |
| 2009 | 0 | 1 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 3 |
| 2015 | 3 | 3 |
| 2016 | 2 | 3 |
| 2017 | 3 | 8 |
| 2018 | 3 | 13 |
| 2019 | 7 | 10 |
| 2020 | 10 | 13 |
| 2021 | 9 | 9 |
| 2022 | 9 | 6 |
| 2023 | 2 | 6 |
| 2024 | 8 | 9 |
| 2025 | 6 | 11 |
| 2026 | 3 | 5 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency29 Sep 2026US 12,747,429 B2The Trustees of the University of Pennsylvania
- Compositions and methods for delivery of nucleic acids2 Jun 2026US 12,642,870 B2Poseida Therapeutics, Inc.
- Compositions and methods for the treatment of metabolic liver disorders3 Feb 2026US 12,540,335 B2Poseida Therapeutics, Inc.
- Methods for purification of messenger RNA9 Sep 2025US 12,410,422 B2Translate Bio, Inc.
- Compositions and methods for treating ornithine transcarbamylase deficiency26 Aug 2025US 12,398,379 B2Arcturus Therapeutics, Inc.
- Method for the fermentative production of guanidinoacetic acid using a microorganism comprising a heterologous l-threonine 3-dehydrogenase gene (tdh) and a glycine c-acetyltransferase gene (kbl)6 Aug 2026US 2026/0226404 A1Evonik Operations GmbH
- Compositions and methods for the treatment of metabolic liver disorders30 Jul 2026US 2026/0218236 A1Poseida Therapeutics, Inc.
- Fermentative production guanidinoacetic acid (gaa) from serine by attenuating l serine ammonia lyase activity in microorganisms30 Jul 2026US 2026/0218253 A1Evonik Operations GmbH
- Compositions and methods for treating ornithine transcarbamylase deficiency19 Mar 2026US 2026/0078356 A1Arcturus Therapeutics, Inc.
- Methods for purification of messenger rna19 Feb 2026US 2026/0049299 A1
Most cited
By later US patents
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor288US 7,282,199 B2The Trustees of the University of Pennsylvania · 2007
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor220US 7,790,449 B2The Trustees of the University of Pennsylvania · 2010
- mRNA for use in treatment of human genetic diseases131US 8,853,377 B2Shire Human Genetic Therapies, Inc. · 2014
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor91US 8,318,480 B2The Trustees of the University of Pennsylvania · 2012
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor86US 8,962,332 B2The Trustees of the University of Pennsylvania · 2015